Skip to main content

Advertisement

Log in

Hematopoietic- and Neurologic-Expressed Sequence 1 Expression in the Murine GL261 and High-Grade Human Gliomas

  • Original Paper
  • Published:
Pathology & Oncology Research

Abstract

The hematopoietic- and neurologic-expressed sequence 1 (Hn1) gene encodes a highly conserved protein that is expressed in developing and regenerating tissues. In this study, Hn1 expression was evaluated in human and murine malignant gliomas. Hn1 mRNA and protein were detected in the murine GL261 glioma cell line and in GL261 brain tumors in vivo. HN1 is also expressed in human U118MG and U87MG cell lines. Evaluation of human brain tumors using an anti-Hn1 polyclonal antibody detected strong immunoreactivity in high-grade (WHO III and IV) malignant gliomas. The rate of GL261 cell proliferation in vitro was unaltered by Hn1 depletion using an anti-Hn1 siRNA. However, tumors established from Hn1-depleted GL261 cells formed significantly smaller volumes than those established from control-treated cells. These data suggest a role for Hn1 in the biology of malignant brain tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Zujovic V, Luo D, Baker HV, Lopez MC, Miller KR, Streit WJ, Harrison JK (2005) The facial motor nucleus transcriptional program in response to peripheral nerve injury identifies Hn1 as a regeneration-associated gene. J Neurosci Res 82:581–591

    Article  CAS  PubMed  Google Scholar 

  2. Goto T, Hisatomi O, Kotoura M, Tokunaga F (2006) Induced expression of hematopoietic- and neurologic-expressed sequence 1 in retinal pigment epithelial cells during newt retina regeneration. Exp Eye Res 83:972–980

    Article  CAS  PubMed  Google Scholar 

  3. Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, Smith D, Hartmann L, Fishman D, Berchuck A, Schmandt R, Whitaker R, Gershenson DM, Mills GB, Bast RC, Jr. (2004) Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 10:3291–3300

    Article  CAS  PubMed  Google Scholar 

  4. Tang W, Lai YH, Han XD, Wong PM, Peters LL, Chui DH (1997) Murine Hn1 on chromosome 11 is expressed in hemopoietic and brain tissues. Mamm Genome 8:695–696

    Article  CAS  PubMed  Google Scholar 

  5. Zhou G, Wang J, Zhang Y, Zhong C, Ni J, Wang L, Guo J, Zhang K, Yu L, Zhao S (2004) Cloning, expression and subcellular localization of HN1 and HN1L genes, as well as characterization of their orthologs, defining an evolutionarily conserved gene family. Gene 331:115–123

    Article  CAS  PubMed  Google Scholar 

  6. Zimmerman HM, Arnold H (1941) Experimental brain tumors. I. Tumors produced with methylcholanthrene. Cancer Res 919–924

  7. Ausman JI, Shapiro WR, Rall DP (1970) Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Res 30:2394–2400

    CAS  PubMed  Google Scholar 

  8. Szatmari T, Lumniczky K, Desaknai S, Trajcevski S, Hidvegi EJ, Hamada H, Safrany G (2006) Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci 97:546–553

    Article  CAS  PubMed  Google Scholar 

  9. San-Galli F, Vrignaud P, Robert J, Coindre JM, Cohadon F (1989) Assessment of the experimental model of transplanted C6 glioblastoma in Wistar rats. J Neurooncol 7:299–304

    Article  CAS  PubMed  Google Scholar 

  10. Weiner NE, Pyles RB, Chalk CL, Balko MG, Miller MA, Dyer CA, Warnick RE, Parysek LM (1999) A syngeneic mouse glioma model for study of glioblastoma therapy. J Neuropathol Exp Neurol 58:54–60

    Article  CAS  PubMed  Google Scholar 

  11. Ishii N, Tada M, Hamou MF, Janzer RC, Meagher-Villemure K, Wiestler OD, Tribolet N, Van Meir EG (1999) Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Oncogene 18:5870–5878

    Article  CAS  PubMed  Google Scholar 

  12. Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49:4682–4689

    CAS  PubMed  Google Scholar 

  13. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B (1992) Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846–847

    Article  CAS  PubMed  Google Scholar 

  14. Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81:1991–1995

    Article  CAS  PubMed  Google Scholar 

  15. Harris J, Ayyub C, Shaw G (1991) A molecular dissection of the carboxyterminal tails of the major neurofilament subunits NF-M and NF-H. J Neurosci Res 30:47–62

    Article  CAS  PubMed  Google Scholar 

  16. McCarty DM, Monahan PE, Samulski RJ (2001) Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther 8:1248–1254

    Article  CAS  PubMed  Google Scholar 

  17. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ, Jr., Chiodo VA, Phillipsberg T, Muzyczka N, Hauswirth WW, Flotte TR, Byrne BJ, Snyder RO (2002) Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28:158–167

    Article  CAS  PubMed  Google Scholar 

  18. Harrison JK, Luo D, Streit WJ (2003) In situ hybridization analysis of chemokines and chemokine receptors in the central nervous system. Methods 29:312–318

    Article  CAS  PubMed  Google Scholar 

  19. Qiu J, Ai L, Ramachandran C, Yao B, Gopalakrishnan S, Fields CR, Delmas AL, Dyer LM, Melnick SJ, Yachnis AT, Schwartz PH, Fine HA, Brown KD, Robertson KD (2008) Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas. Lab Invest 88:910–925

    Article  CAS  PubMed  Google Scholar 

  20. Liu C, Luo D, Streit WJ, Harrison JK (2008) CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes. J Neuroimmunol 198:98–105

    Article  CAS  PubMed  Google Scholar 

  21. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109

    Article  PubMed  Google Scholar 

  22. Pescarmona GP, Scalerandi M, Delsanto PP, Condat CA (1999) Non-linear model of cancer growth and metastasis: a limiting nutrient as a major determinant of tumor shape and diffusion. Med Hypotheses 53:497–503

    Article  CAS  PubMed  Google Scholar 

  23. Seiki M (2003) Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 194:1–11

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Financial support for these studies was provided by the Evelyn F. and William L. McKnight Brain Institute of the University of Florida and the National Institutes of Health (AI058256) to J.K.H. We are thankful to Ms. Irene Zolotukhin for manufacturing the adeno-associated viruses utilized in this study. The anti-Hn1 antibody used in this study was generated at EnCor Biotechnology, Inc., Gainesville, Florida. A portion of these data were presented at the 2007 annual meetings of the Society for Neuroscience in San Diego, CA and Society for Neuro-oncology in Dallas, TX.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey K. Harrison.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laughlin, K.M., Luo, D., Liu, C. et al. Hematopoietic- and Neurologic-Expressed Sequence 1 Expression in the Murine GL261 and High-Grade Human Gliomas. Pathol. Oncol. Res. 15, 437–444 (2009). https://doi.org/10.1007/s12253-008-9147-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-008-9147-4

Keywords

Navigation